A549 |
culture of human lung carcinoma cell line |
BET |
bromodomain and extraterminal domain |
BMP |
bone marrow protein |
CT |
computed tomography |
DDR |
DNA damage response |
DNA |
deoxyribonucleic acid |
DNA-PKcs |
DNA-protein kinase catalytic subunit |
DSB |
double-strand break |
ECM |
extracellular matrix |
ED-A-FN |
extradomain-A fibronectin |
G0/G1 |
gap 0/gap 1 |
HIF |
hypoxia-inducible factor |
IFN |
interferon |
Il |
interleukin |
IR |
ionizing radiation |
KL-6 |
glycoprotein Krebs von den Lugen-6 |
K-ras |
Kirsten rat sarcoma |
MAPK |
mitogen-activated protein kinase |
MMP |
matrix metalloproteinases |
MUC1 |
mucin 1 |
NFκB1 |
nuclear factor κB1 |
NK |
natural killer |
NO |
nitric oxygen |
NSCLC |
non-small cell lung carcinoma |
OS |
overall survival |
PDGF |
platelet-derived growth factor |
PI3K |
phosphoinositide 3-kinase |
RILD |
radiation-induced lung disease |
RILF |
radiation-induced lung fibrosis |
RILI |
radiation-induced lung injury |
ROS |
reactive oxygen species |
RP |
radiation-induced pneumonitis |
RT |
radiotherapy |
SCC |
squamous cell carcinoma |
SCLC |
small cell lung carcinoma |
SENP1 |
sentrin-specific protease 1 |
SNP |
single nucleotide polymorphism |
SP |
surfactant protein |
SSB |
single-strand break |
surfactant |
surface-active agent |
TGFβ |
transforming growth factor β |
TNFα |
tumor necrosis factor α |
TNM |
TNM Classification of Malignant Tumors (tumor-lymph nodes-metastasis |
VCAN |
versican |
WHO |
World Health Organization |